PMID- 19654407 OWN - NLM STAT- MEDLINE DCOM- 20091202 LR - 20211020 IS - 1528-0020 (Electronic) IS - 0006-4971 (Print) IS - 0006-4971 (Linking) VI - 114 IP - 14 DP - 2009 Oct 1 TI - Donor-recipient mismatches in MHC class I chain-related gene A in unrelated donor transplantation lead to increased incidence of acute graft-versus-host disease. PG - 2884-7 LID - 10.1182/blood-2009-05-223172 [doi] AB - The polymorphic products of major histocompatibility complex class I-related chain A (MICA) genes are important in solid organ transplantation rejection. MICA expression is limited to gut epithelium and may play a role in triggering acute graft-versus-host disease (aGVHD). A total of 236 recipients of unrelated donor transplantation were studied. Donor-recipient human leukocyte antigen (HLA) match was 10/10 human leukocyte antigen (HLA-A, -B, -C, -DRB1, -DQB1) in 73% and MICA mismatch in 8.4%. Because of physical vicinity of the loci, MICA mismatch was significantly associated with mismatch at HLA-B and HLA-C. A higher rate of grade II-IV aGVHD was seen in MICA-mismatched patients (80% vs 40%, P = .003) irrespective of degree of HLA matching (HLA 10/10 match: 75% vs 39%, P = .02) and HLA any mismatch (83% vs 46%, P = .003). The rate of grade II-IV gastrointestinal aGVHD was also higher in MICA-mismatched patients (35% vs 17%, P = .05). We conclude that MICA may represent novel a transplantation antigen recognized by human allogeneic T cells. This study was registered at ClinicalTrials.gov (Identifier NCT00506922). FAU - Parmar, Simrit AU - Parmar S AD - Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. FAU - Del Lima, Marcos AU - Del Lima M FAU - Zou, Yizhou AU - Zou Y FAU - Patah, Poliana A AU - Patah PA FAU - Liu, Ping AU - Liu P FAU - Cano, Pedro AU - Cano P FAU - Rondon, Gabriela AU - Rondon G FAU - Pesoa, Susana AU - Pesoa S FAU - de Padua Silva, Leandro AU - de Padua Silva L FAU - Qazilbash, Muzaffar H AU - Qazilbash MH FAU - Hosing, Chitra AU - Hosing C FAU - Popat, Uday AU - Popat U FAU - Kebriaei, Partow AU - Kebriaei P FAU - Shpall, Elizabeth J AU - Shpall EJ FAU - Giralt, Sergio AU - Giralt S FAU - Champlin, Richard E AU - Champlin RE FAU - Stastny, Peter AU - Stastny P FAU - Fernandez-Vina, Marcelo AU - Fernandez-Vina M LA - eng SI - ClinicalTrials.gov/NCT00506922 PT - Journal Article DEP - 20090804 PL - United States TA - Blood JT - Blood JID - 7603509 SB - IM CIN - Blood. 2009 Nov 19;114(21):4753-4; author reply 4754-5. PMID: 19965715 MH - Adolescent MH - Adult MH - Aged MH - *Blood Donors MH - Female MH - Genes, MHC Class I/*genetics MH - Genotype MH - Graft Rejection MH - Graft vs Host Disease/*etiology/*mortality MH - *Hematopoietic Stem Cell Transplantation MH - *Histocompatibility MH - Histocompatibility Testing MH - Humans MH - Incidence MH - Leukemia, Myeloid, Acute/*therapy MH - Male MH - Middle Aged MH - Prognosis MH - Prospective Studies MH - Risk Factors MH - Survival Rate MH - Treatment Outcome MH - Young Adult PMC - PMC4784289 EDAT- 2009/08/06 09:00 MHDA- 2009/12/16 06:00 PMCR- 2009/10/01 CRDT- 2009/08/06 09:00 PHST- 2009/08/06 09:00 [entrez] PHST- 2009/08/06 09:00 [pubmed] PHST- 2009/12/16 06:00 [medline] PHST- 2009/10/01 00:00 [pmc-release] AID - S0006-4971(20)36825-7 [pii] AID - 2009/223172 [pii] AID - 10.1182/blood-2009-05-223172 [doi] PST - ppublish SO - Blood. 2009 Oct 1;114(14):2884-7. doi: 10.1182/blood-2009-05-223172. Epub 2009 Aug 4.